Evidence map›Paper›PMID 26828794›Full record

ArticlePloS one2016

Crystal Structure of a Ube2S-Ubiquitin Conjugate.

Sonja Lorenz, Moitrayee Bhattacharyya, Christian Feiler, Michael Rape, John Kuriyan

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Review
  2. Chemical Tools for Probing the Ub/Ubl Conjugation Cascades.Chembiochem : a European journal of chemical biology · 2025
    Review
  3. Article
  4. Article
  5. Cocrystallization of ubiquitin-deubiquitinase complexes through disulfide linkage.Acta crystallographica. Section D, Structural biology · 2023
    Article
  6. Article
  7. From seeds to trees: how E2 enzymes grow ubiquitin chains.Biochemical Society transactions · 2023
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Enzymatic Logic of Ubiquitin Chain Assembly.Frontiers in physiology · 2019
    Review
  17. Review
  18. Ube2s expression is elevated in hepatocellular carcinoma and predicts poor prognosis of the patients.International journal of clinical and experimental pathology · 2018
    Article
  19. Review
  20. Ubiquitin modifications.Cell research · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sonja LorenzCalifornia Institute for Quantitative Biosciences, University of California, Berkeley, California, United States of America.
Moitrayee BhattacharyyaCalifornia Institute for Quantitative Biosciences, University of California, Berkeley, California, United States of America.
Christian FeilerRudolf Virchow Center for Experimental Biomedicine, University of Würzburg, Würzburg, Germany.
Michael RapeCalifornia Institute for Quantitative Biosciences, University of California, Berkeley, California, United States of America.
John KuriyanCalifornia Institute for Quantitative Biosciences, University of California, Berkeley, California, United States of America.

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

Protein ubiquitination occurs through the sequential formation and reorganization of specific protein-protein interfaces. Ubiquitin-conjugating (E2) enzymes, such as Ube2S, catalyze the formation of an isopeptide linkage between the C-terminus of a "donor" ubiquitin and a primary amino group of an "acceptor" ubiquitin molecule. This reaction involves an intermediate, in which the C-terminus of the donor ubiquitin is thioester-bound to the active site cysteine of the E2 and a functionally important interface is formed between the two proteins. A docked model of a Ube2S-donor ubiquitin complex was generated previously, based on chemical shift mapping by NMR, and predicted contacts were validated in functional studies. We now present the crystal structure of a covalent Ube2S-ubiquitin complex. The structure contains an interface between Ube2S and ubiquitin in trans that resembles the earlier model in general terms, but differs in detail. The crystallographic interface is more hydrophobic than the earlier model and is stable in molecular dynamics (MD) simulations. Remarkably, the docked Ube2S-donor complex converges readily to the configuration seen in the crystal structure in 3 out of 8 MD trajectories. Since the crystallographic interface is fully consistent with mutational effects, this indicates that the structure provides an energetically favorable representation of the functionally critical Ube2S-donor interface.

Indexed as

Crystallography, X-RayLysineMagnetic Resonance SpectroscopyMolecular Dynamics SimulationStructural Homology, ProteinUbiquitinUbiquitin-Conjugating EnzymesLysineUbiquitinUbiquitin-Conjugating Enzymes

Identifiers

PMID26828794
PMCPMC4734694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.